glp 1 agonist vs bariatric surgery Outperforms GLP-1s in Weight Loss Bariatric Surgery vs. GLP-1 Drugs
Description
In a response to questions about Pfizer ending the trial of its oral drug, a company spokesperson pointed Scientific American to the press release that announced that decision and said Pfizer is working on other early-stage oral drug candidates for weight loss, including one that works on a similar hormone to GLP-1 that is currently in phase 2 clinical trials
doi: 10.2337/db13-1440
This is especially useful for clinics, weight loss programs, and patients who need customized care
Patients had received new prescriptions between January and December 2021, and all were diagnosed with obesity
The medication may interfere with the psychological control that binge eating has on the person by reducing the motivations of hunger and reward
In addition, GLP-1s have the potential to impact substance or alcohol use disorder and Prader-Willi syndrome through their effect on satiety hormones
